The use of medical scribes hired to enter information into electronic health records (EHRs) has increased substantially, but can pose potential risks, according to a new article in JAMA.
The use of medical scribes hired to enter information into electronic health records (EHRs) has increased substantially, but can pose potential risks, according to a new Viewpoint article in JAMA.
According to data from the American College of Medical Scribe Specialists, in 6 years there will be 1 medical scribe for every 9 physicians in the US. However, the authors—George A. Gellert, MD, MPH, MPA; Ricardo Ramirea, LVN, and S. Luke Webster, MD, from CHRISTUS Health—view the increased use of medical scribes as a workaround of the suboptimal state of EHRs. They argue that if physician dissatisfaction with EHRs decreases because they interact with the technology less, then collective market pressure to evolve EHR usability will reduce.
“By reducing market demand and pressure on industry for needed improvements, the medical scribe industry (and inadvertently its customers) may contribute to an unintended, undesirable outcome: a deceleration and possibly stagnation in EHR technological improvement,” they write.
Furthermore, the authors expressed concerned about the use of medical scribes for computerized patient order entry (CPOE). The Joint Commission has noted that scribes may assist with EHR navigation, retrieval of diagnostic results, documentation, and coding, but cannot enter orders in a patient’s electronic record. Meanwhile, CMS has stated that it does not believe anyone should be allowed to enter orders using CPOE.
Despite the prohibition on the use of scribes for order entry, some physicians advocate the use of medical scribes for CPOE and regard it as clerical work. However, Gellert et al argue that only trained physicians can appropriately interpret decision support alerts that appear during CPOE.
The authors conclude that scribe support is not the answer to today’s inadequate EHRs. Rather, they encourage physicians to demand improved products to foster the rapid evolvement of EHRs.
“The rise of the medical scribe industry should not be a substitute for much-needed EHR innovation and transition to more highly effective and more functionally efficient EHR systems,” they write.
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More